FDA Drug Recalls
17,898 recalls, newest first
Class II · Moderate risk Ongoing Oct 7, 2025
Reason Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).
Class II · Moderate risk Ongoing Oct 6, 2025
Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
Class II · Moderate risk Ongoing Oct 6, 2025
Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
Class II · Moderate risk Ongoing Oct 6, 2025
Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
Class II · Moderate risk Ongoing Oct 6, 2025
Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
Class II · Moderate risk Ongoing Oct 6, 2025
Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
Class II · Moderate risk Ongoing Oct 6, 2025
Reason CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
Class II · Moderate risk Ongoing Oct 6, 2025
Reason Discoloration
Class II · Moderate risk Ongoing Oct 3, 2025
Reason Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
Class II · Moderate risk Ongoing Oct 1, 2025
Reason Labeling: Label Mix-up: The product in the bottle contains elderberry and the label failed to indicate the inclusion of elderberry as an ingredient.
Class II · Moderate risk Ongoing Oct 1, 2025
Reason Presence of Particulate Matter: Particulate matter identified as glass
Class II · Moderate risk Ongoing Sep 29, 2025
Reason Subpotent Drug
Class II · Moderate risk Ongoing Sep 29, 2025
Reason Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
Class II · Moderate risk Ongoing Sep 29, 2025
Reason cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.
Class II · Moderate risk Ongoing Sep 29, 2025
Reason cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.
Class II · Moderate risk Ongoing Sep 26, 2025
Reason Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Class II · Moderate risk Ongoing Sep 25, 2025
Reason cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.
Class II · Moderate risk Ongoing Sep 24, 2025
Reason Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity
Class II · Moderate risk Ongoing Sep 24, 2025
Reason Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity
Class II · Moderate risk Ongoing Sep 23, 2025
Reason CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
Class II · Moderate risk Ongoing Sep 23, 2025
Reason Product Mix-up
Class II · Moderate risk Terminated Sep 22, 2025
Reason Lack of assurance of sterility.
Class II · Moderate risk Ongoing Sep 19, 2025
Reason Failed Dissolution Specifications
Class II · Moderate risk Ongoing Sep 19, 2025
Reason Failed Dissolution Specifications
Class II · Moderate risk Ongoing Sep 19, 2025
Reason Failed Dissolution Specifications